A Randomized, Double-blind, Placebo-controlled, Phase III Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo.

Trial Profile

A Randomized, Double-blind, Placebo-controlled, Phase III Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Apr 2011

At a glance

  • Drugs Fluorouracil; Folinic acid; Oxaliplatin; Vatalanib
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Acronyms CONFIRM-1
  • Most Recent Events

    • 04 Apr 2011 Results published in the Journal of Clinical Oncology.
    • 04 Nov 2008 Updated from ClinicalTrials.gov record.
    • 23 Sep 2007 Results were presented at ECCO 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top